Outlook Therapeutics, Inc.
BiotechnologyOphthalmic Biopharmaceuticals
Iselin, NJ
About
Outlook Therapeutics is a pioneering biopharmaceutical company specializing in the development and commercialization of ophthalmic medications. The company is committed to addressing significant unmet medical needs in the treatment of retinal diseases through innovative therapeutic solutions.
Company Values
Outlook Therapeutics distinguishes itself by developing the first FDA-approved ophthalmic formulation of bevacizumab, directly addressing a current gap in the treatment of retinal diseases like wet AMD.